The first stop for professional medicines advice

Medicines planning

62 results

Applied filters

Good governance when implementing eculizumab biosimilar

6 March 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.

Delegation of roles under a PGD

19 March 2024Delegation of any PGD function is not permitted. However there are specific tasks that individuals other than the professional working under a PGD can fulfil.

What's new in PGDs and medicines mechanisms: an update

1 May 2024An update session for those managing and using PGDs and other medicine mechanisms in practice

Legal mechanisms and contrast agents

15 July 2024Informing and supporting decision making when considering the most appropriate legal mechanism for administering contrast agents in imaging services.

Preparing to use ustekinumab biosimilar

16 July 2024Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.

Planning for a PGD

30 July 2024You’ve decided a PGD is the most appropriate option but there are things to consider before you start writing.

Authorising and preparing to use a PGD

30 July 2024Once a PGD is written, there are steps to be completed before the PGD is used within an organisation.

Writing a PGD

30 July 2024Writing a PGD is a multi-step process, requiring input from all members of the PGD development team.

Monitoring and reviewing a PGD in practice

30 July 2024Monitoring and evaluating practice under a PGD and timely review of a PGD are important steps in the development process.

The licence and supporting evidence for ustekinumab biosimilars

2 August 2024Ustekinumab biosimilars (Pyzchiva, Uzpruvo, Wezenla) are licensed. Learn about the indications, available formulations, supporting evidence and differences.